Reditux 100 mg Injection
$94.21
$37.54
Reditux 100 mg Injection is a targeted monoclonal antibody therapy that plays a crucial role in managing various immune-related disorders. This innovative treatment is primarily indicated for certain malignancies, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia, providing hope for patients battling these conditions. By selectively binding to the CD20 protein found on the surface of B cells, Reditux effectively disrupts the growth and survival of cancerous cells, promoting their destruction by the immune system. While generally well-tolerated, it's important for patients to be aware of potential side effects, which may include infusion reactions and an increased risk of infections. Regular monitoring during treatment is essential to ensure optimal safety and effectiveness. As a vital component of cancer therapy, Reditux offers a pathway to better outcomes for individuals facing challenging diagnoses. Always consult with a healthcare professional for personalized guidance and to discuss any concerns related to its use.
Quantity
Active Pharmaceutical Ingredient
Uses
• Reditux 100 mg injection is primarily used in the treatment of Non-Hodgkin lymphoma (NHL). This type of cancer affects the lymphatic system, which is crucial for immune function. The medication works by targeting specific cells in the body, helping to reduce the number of cancerous cells. Patients receiving Reditux 100 mg injection often see an improvement in their overall health and quality of life.
• Another significant use of Reditux 100 mg injection is in the management of rheumatoid arthritis. This autoimmune condition causes chronic inflammation in the joints, leading to pain and disability. Reditux 100 mg injection helps modulate the immune response, reducing inflammation and alleviating symptoms. Patients often report enhanced mobility and reduced joint pain after treatment.
• Reditux 100 mg injection is also indicated for patients with chronic lymphocytic leukaemia (CLL), a type of blood cancer. CLL is characterized by the accumulation of abnormal lymphocytes in the blood and bone marrow. By using Reditux 100 mg injection, healthcare providers aim to decrease the number of these abnormal cells. This treatment can lead to better disease management and improved patient outcomes.
• Additionally, Reditux 100 mg injection is utilized in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis. These are rare autoimmune diseases that cause inflammation of blood vessels, impacting various organs. The administration of Reditux 100 mg injection helps to control the immune system's activity, thus reducing inflammation and preventing further damage. Patients often experience a stabilization of their condition with this targeted therapy.
Benefits
Non-Hodgkin lymphoma (NHL): Non-Hodgkin's lymphoma is a form of cancer that affects the white blood cells in the body. These cells are responsible for preventing infections. Reditux 100 mg Injection has been demonstrated to reduce the immune response and relieve pain and inflammation. It also can kill cancer cells and prevent their further growth. To prevent the spread of infection, it is advisable to avoid crowds and to wash your hands frequently. It is recommended that patients consume an adequate quantity of fluids unless otherwise advised by their physician.
Rheumatoid arthritis: Reditux 100 mg is an immunosuppressant that is used to treat rheumatoid arthritis. It is administered in a dose and frequency that is tailored to the patient's condition. This is determined by the physician. It is crucial to adhere to the physician's instructions and to promptly report any adverse effects, including fever, chills, or other symptoms, to the physician.
Blood cancer (chronic lymphocytic leukemia): Leukemia, also known as blood cancer, is a malignant neoplasm of the hematopoietic tissues that impairs the body's ability to combat infection. Reditux 100 Injection is a chemotherapeutic agent that kills or inhibits the proliferation of malignant cells and is effective in the treatment of leukemia. However, it is important to discuss the potential side effects and benefits of this medication with a qualified healthcare professional. It is also essential to inform your doctor of any adverse effects that may arise during treatment.
Granulomatosis with polyangiitis: Granulomatosis with polyangiitis (GPA) is a condition that causes inflammation of the blood vessels of the ears, nose, throat, lungs, and kidneys. In this condition, the blood flow to these areas may be reduced, which can lead to their damage. Reditux 100 mg Injection is an effective treatment that helps reduce inflammation, pain, and swelling and prevents further damage. This improves the quality of life of those affected by GPA.
Microscopic polyangiitis: Microscopic polyangiitis is an autoimmune disease that affects the small blood vessels and may be caused by an imbalance in the immune system. Reditux 100 mg Injection reduces the immune response and improves inflammation. This helps to heal the condition and to alleviate discomfort.
Side Effects
Reditux 100 mg Injection can cause various adverse effects that can differ from one person to another. Some of the adverse effects of the drug are listed below.
Most Common Side Effects
• Low Immunity
• Nausea
• Tinnitus
• Muscle Pain and Stiffness
• Face Swelling
• Low Blood Count of White Blood Cells and Red Blood Cells
• Increase in Glucose Levels in Blood
• Headache
Common Side Effects
• Skin Reactions
• Heart Problems
• Infections
• Allergies
How To Use
The administration of Reditux 100 Injection is typically conducted by a medical professional, such as a doctor or nurse, in a medical facility, such as a hospital or clinic. It is not advisable to administer the product independently, and it is important to adhere to the instructions provided by a qualified healthcare professional.
Safety Advice
• Alcohol: Caution should be exercised when drinking alcohol with Reditux 100 mg. Please consult your doctor.
• Kidney: Reditux 100 mg Injection is likely to be safe in patients with kidney disease. The limited data available suggest that dose adjustment of Vortuxi Solution for Infusion may not be necessary for these patients. Please consult your doctor.
• Breastfeeding: Reditux 100 mg Injection is likely to be safe to use while breastfeeding, and limited human statistics support that the drug now no longer poses a good risk to the baby.
• Liver: Reditux 100 mg Injection is not recommended in patients with active liver disease or those who have had viral hepatitis. Please consult your doctor.
• Pregnancy: Reditux 100 mg Injection may not be safe for use during pregnancy. Although there is limited human research, animal research has shown dangerous effects on the growing baby. Your doctor will weigh up the benefits and potential risks before prescribing it to you. Please consult your doctor.
• Driving: It is not known whether Reditux 100 mg affects your ability to drive. Do not drive if you experience symptoms that affect your ability to concentrate and react.